US20040034275A1 - Multi-material incontinence treatment constriction device - Google Patents

Multi-material incontinence treatment constriction device Download PDF

Info

Publication number
US20040034275A1
US20040034275A1 US10463873 US46387303A US2004034275A1 US 20040034275 A1 US20040034275 A1 US 20040034275A1 US 10463873 US10463873 US 10463873 US 46387303 A US46387303 A US 46387303A US 2004034275 A1 US2004034275 A1 US 2004034275A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
material
device
constriction
layer
implantable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10463873
Inventor
Peter Forsell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ABDOMICA AG
PROSTHESICA AG
Original Assignee
Peter Forsell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/34Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • A61L27/306Other specific inorganic materials not covered by A61L27/303 - A61L27/32
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/082Inorganic materials
    • A61L31/088Other specific inorganic materials not covered by A61L31/084 or A61L31/086
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/10Macromolecular materials

Abstract

An implantable constriction device for treating an incontinent patient comprises an elongate composite structure adapted to constrict the urethra, urine bladder, anus, colon or rectum of the patient. The elongate composite structure is composed of a base material, such as hard silicone, making the composite structure self-supporting. Property improving means is provided for improving at least one physical property of the composite structure other than self-supporting properties, such as fatigue resistance, liquid impermeability, aggressive body cells resistance, anti-friction properties and lifetime.

Description

  • [0001]
    This application claims the benefit of Provisional Application No. 60/398,824, filed Jul. 29, 2002, the entire contents of which is hereby incorporated by reference in this application.
  • BACKGROUND OF THE INVENTION
  • [0002]
    The present invention relates to an implantable constriction device for constricting the urethra, urine bladder, anus, colon or rectum of an incontinent patient.
  • [0003]
    This kind of constriction device, in the form of a banding device in which a band encircles and adjustably constricts a portion of a patient's urethra, urine bladder, anus, colon or rectum, has been used in surgery for treating anal and urinary incontinence. In practice, the band is made of silicone, which is a material approved and widely used for implantation. Moreover, the silicone band has an acceptable tensile strength and is fairly resistant to aggressive body fluids. Where the band is hydraulically adjusted, the hydraulic fluid used typically is an isotonic salt solution mixed with other conventional materials.
  • [0004]
    A problem with traditional silicone bands, however, is that the silicone material gives the band certain inadequate properties, such as poor fatigue resistance and poor endurance of static bending forces, which over time might result in breakage of the band. Furthermore, silicone is a material that is semi-permeable by liquid, which is a drawback to hydraulic silicone bands, because hydraulic fluid can escape by diffusing through the silicone material. As a result, accurate adjustments of a hydraulic band are difficult to perform because of the loss of hydraulic fluid and the need for the patient to regularly visit a doctor to add hydraulic fluid to and calibrate the constriction device. These inadequate properties are serious, considering that the band is implanted for the rest of the patient's life. Another problem is that the band somewhat restrains the dynamic movements of adjacent organs necessary for the transportation of urine or fecal matter. As a consequence, the band might erode, and over time injure the urethra, urine bladder, anus, colon or rectum.
  • SUMMARY OF THE INVENTION
  • [0005]
    The object of the present invention is to provide a new implantable constriction device for treating urinary and anal incontinence having improved properties as compared to traditional constriction devices.
  • [0006]
    Accordingly, the present invention provides an implantable constriction device for treating an incontinent patient, the device comprising an elongate composite structure adapted to constrict the urethra, urine bladder, anus, colon or rectum of the patient, wherein the elongate composite structure is composed of a base material making the composite structure self-supporting and property improving means for improving at least one physical property of the composite structure other than self-supporting properties.
  • [0007]
    In accordance with a first embodiment of the invention, the property improving means comprises a coating on the base material at least along a side of the elongate composite structure that is intended to contact the urethra, urine bladder, anus, colon or rectum, wherein the coating has better aggressive body fluid resistance than the base material. Such a coating may comprise a Teflon™ or Parylene™ coating, or a biocompatible metal coating such as gold, silver or titanium. As a result, the constriction device can be protected from damaging influences of aggressive body fluids, possibly for the rest of the patient's life.
  • [0008]
    Where traditional silicone material constitutes the base material, a Teflon™ or Parylene™ coating also provides the composite structure with better anti-friction properties than the base material. Good anti-friction properties of the composite structure reduce the risk of the elongate composite structure eroding the urethra, urine bladder, anus, colon or rectum. This is proven by tests, in which the surface of traditional silicone bands has been polished before use. Accordingly, the test results indicate significant improvements in avoiding erosion of the urethra, urine bladder, anus, colon or rectum.
  • [0009]
    Furthermore, the Teflon™, Parylene™ or metal coating also makes the composite structure, in which the base material is made of silicone, stronger than the traditional silicone band. A stronger band reduces the risk of fracture.
  • [0010]
    In one alternative to the first embodiment, the elongate composite structure is designed for mechanical adjustment, such as the mechanical solutions disclosed in International Application No. WO 01/45486. In this alternative, the property improving means comprises a core of a soft viscoelastic material, such as silicone gel, typically having a hardness less than 20 Shure, cellulose gel or collagen gel. Where silicone gel is chosen, it may be “Med 3-6300” manufactured by Nusil. Hard silicone constitutes the base material, typically having a hardness of at least 60 Shure, and covers the soft core of viscoelastic material. The soft core makes the implanted elongate composite structure less injurious to the urethra, urine bladder, anus, colon or rectum, and reduces the injury of such organs. Furthermore, the soft core of viscoelastic material may be formed to enclose and protect mechanical adjustment components and other components of the composite structure, whereby fibrosis is prevented from growing into such components.
  • [0011]
    In another alternative to the first embodiment, the elongate composite structure is designed for hydraulic adjustment, such as the hydraulic solutions disclosed in International Application No. WO 01/50833. In this alternative, the base material forms a closed tubing, which can be inflated by adding hydraulic fluid to the interior of the tubing and deflated by withdrawing hydraulic fluid from the interior of the tubing. The coating of Teflon™, Parylene™ or metal may cover the inner surface of the tubing. The base material may form two coaxial tubular layers of hard silicon, and the property improving means may comprise a tubular intermediate layer of a soft viscoelastic material located between the coaxial tubular layers. Alternatively, the base material may form an outer tubular layer and an inner arcuate layer attached to the outer tubular layer, the outer and inner layers defining a curved space extending longitudinally along the tubing. The property improving means may comprise a viscoelastic material filling the space. The tubing is applied around the urethra, urine bladder, anus, colon or rectum so that the space with viscoelastic material is located closest to the urethra, urine bladder, anus, colon or rectum. The viscoelastic material gives the advantages that erosion of the urethra, urine bladder, anus, colon or rectum is reduced and the risk of hydraulic fluid leaking from the tubing is decreased.
  • [0012]
    In accordance with a second embodiment of the invention, the base material forms a first layer and the property improving means comprises a second layer applied on the first layer, wherein the second layer is more fatigue resistant than the first layer. The first layer preferably is comprised of hard silicone, whereas the second layer preferably is comprised of a polyurethane layer. In a traditional silicone band, especially the tubular type, that is formed in a loop to constrict the urethra, urine bladder, anus, colon or rectum, the inner surface of the band loop that contacts the urethra, urine bladder, anus, colon or rectum forms bulges and creases that repeatedly change as the band is subjected to dynamic movements from the urethra, urine bladder, anus, colon or rectum and when the size of the band is adjusted. As a consequence, the implanted traditional silicone band has the drawback that it may crack after some time due to fatigue of the silicone material. With the elongate composite structure of the invention, in which hard silicone may constitute the base material and a fatigue resistant polyurethane layer covers the silicone material on the side of the elongate composite structure that contacts the urethra, urine bladder, anus, colon or rectum, this drawback is eliminated.
  • [0013]
    The property improving means suitably comprises a coating that may be coated on the layer of hard silicone and/or the layer of polyurethane, wherein the coating has better aggressive body fluid resistance properties and/or better anti-friction properties than hard silicone. As described above in connection with the first embodiment, the coating may comprise a Teflon™ or Parylene™ coating, or a biocompatible metal coating.
  • [0014]
    The layer of hard silicone may form an inflatable tubing and the layer of polyurethane may cover the hard silicone layer within the tubing.
  • [0015]
    In accordance with a third embodiment of the invention, the base material forms an inflatable tubing and the property improving means comprises a liquid impermeable coating coated on the base material. The coating may be coated on the external and/or internal surface of the tubing. Preferably, the liquid impermeable coating comprises a Parylener™ coating, or a biocompatible metal coating. Where hard silicone, which is a liquid semi-permeable material, constitutes the base material, the coating of Parylene™ or metal gives the advantage that the tubing may be inflated by hydraulic fluid under pressure without risking fluid diffusing through the silicone wall of the tubing.
  • [0016]
    Also, in the third embodiment, the base material may form two coaxial tubular layers of hard silicon, and the property improving means may comprise a tubular intermediate layer of a soft viscoelastic material located between the coaxial tubular layers. Alternatively, the base material may form an outer tubular layer of hard silicone and an inner arcuate layer of silicone attached to the outer tubular layer. The outer and inner layers define a curved space extending longitudinally along the tubing and filled with the viscoelastic material. The tubing is intended to be applied around the urethra, urine bladder, anus, colon or rectum so that the space with viscoelastic material is located closest to the urethra, urine bladder, anus, colon or rectum.
  • [0017]
    In accordance with a fourth embodiment of the invention, the property improving means comprises gas, such as air, contained in a multiplicity of cavities formed in the base material to improve the flexibility of the composite structure. In this case, Teflon™ advantageously constitutes the base material. The cavities may be defined by net structures of the Teflon™ material. Thus, the resulting composite structure of Teflon™ and cavities filled with gas is strong, flexible and aggressive body fluid resistant, and has good tensile strength and good anti-friction properties. Also, in the fourth embodiment, the elongate composite structure may comprise an inflatable tubing.
  • [0018]
    The present invention also provides an implantable constriction device for treating an incontinent patient, comprising an elongate composite structure adapted to constrict the urethra, urine bladder, anus, colon or rectum of the patient, wherein the composite structure includes an elongate biocompatible self-supporting base material having surfaces exposed to aggressive body cells, when the constriction device is implanted in the patient, and a cell barrier coating on the surfaces to prevent body cells from breaking down the base material, which is typically silicone. If the base material were broken down by such body cells, typically macrophages or killer cells, histological particles would be spread in the human body.
  • [0019]
    The barrier coating may comprise a Parylene™ coating or a biocompatible metal coating.
  • [0020]
    Alternatively, the barrier coating may comprise a composite of different materials to achieve the cell-barrier protection as described above. There are several examples of such composite materials on the market, for example a composite of polyurethane and silicone called Elaston™.
  • BRIEF DESCRIPTION OF THE DRAWINGS:
  • [0021]
    [0021]FIG. 1 is a front view of a mechanical constriction device according to the present invention.
  • [0022]
    [0022]FIG. 2 is an enlarged cross-section along the line 11-11 in FIG. 1.
  • [0023]
    [0023]FIGS. 3 and 4 are modifications of the embodiment shown in FIG. 2.
  • [0024]
    [0024]FIG. 5 is a front view of a hydraulic constriction device of the invention.
  • [0025]
    [0025]FIG. 6 is an enlarged cross-section along the line VI-VI in FIG. 5.
  • [0026]
    FIGS. 7-10 are modifications of the embodiment shown in FIG. 6.
  • [0027]
    [0027]FIG. 11 is a modification of the embodiment shown in FIG. 2.
  • [0028]
    Referring to the drawing figures, like reference numerals designate identical or corresponding elements throughout the several figures.
  • DETAILED DESCRIPTION OF THE INVENTION
  • [0029]
    [0029]FIG. 1 illustrates a mechanical constriction device 2 according to the invention comprising an elongate composite structure 4 adapted to extend around and constrict the urethra, urine bladder, anus, colon or rectum of a patient. Referring to FIG. 2, the elongate composite structure 4 comprises a strong band 6 of nylon or the like, a tubular layer 8 of hard silicone, in which the band 6 slides, a soft layer 10 of a viscoelastic material, here a silicone gel having a hardness not more than 20 Shure, encircling the hard silicone layer 8, and a tubular layer 12 of a self-supporting base material of hard silicone having a hardness of at least 60 Shure, surrounding the soft silicon layer 10. A coating 14 of Teflon™, Parylene™ or a biocompatible metal, such as gold, silver or titanium, is coated on the outer hard silicone layer 12 to make the composite structure resistant to aggressive body fluids and to give the composite structure good anti-friction properties. A coating of Teflon™, Parylene™ or metal may also be coated on the internal surface of the inner tubular hard silicone layer 8 to reduce the friction between the nylon band 6 and the layer 8. The constriction device 2 has an adjustment means 16 that can displace the end portions of the nylon band 6 relative to each other to either increase or decrease the constriction of the urethra, urine bladder, anus, colon or rectum.
  • [0030]
    [0030]FIG. 3 shows an elongate composite structure 18 similar to that of FIG. 2, except that a layer 20 of a fatigue resistant material, here polyurethane, is applied on the hard silicone layer 12 along the inner side of the structure 18 that is intended to contact the urethra, urine bladder, anus, colon or rectum. Alternatively, the layer 20 may be tubular and surround the layer 12.
  • [0031]
    [0031]FIG. 4 shows a cross-section of an elongate composite structure 22 of an embodiment of the invention, in which Teflon™ constitutes the self-supporting base material, which is formed with a longitudinal cavity in which a strong nylon band 24 slides. Property improving means in the form of a gas, here air, contained in a multiplicity of cavities 26 are formed in the base material to improve the flexibility thereof.
  • [0032]
    [0032]FIGS. 5 and 6 show a hydraulic constriction device 28 according to the invention comprising an elongate composite structure in the form of an inflatable tubing 30, in which the base material of hard silicone forms an outer tubular layer 32 and an inner coaxial layer 34. A viscoelastic material, here soft silicone gel, forms an intermediate layer 36 located between the tubular layers 32 and 34. Four longitudinal partition walls 38 between the tubular layers 32 and 34 divide the intermediate layer 36 into four sections to prevent the silicone gel from displacing in the circumferential direction of the tubing 30. (Also, the embodiments according to FIGS. 2 and 3 may be provided with such longitudinal partition walls.) The outer layer 32 is coated with a coating 40 of Teflon™, Parylener™ or metal. Also, the inner layer 34 may be coated with a coating of Teflon™, Parylene™ or metal. If a Parylene™ or metal coating is chosen the composite structure will be completely liquid impermeable.
  • [0033]
    [0033]FIG. 7 shows a tubing 42 similar to that of FIG. 6, except that an inner arcuate layer 44 is substituted for the inner tubular layer 34. The arcuate layer 44 is attached to the outer tubular layer 32, so that the outer tubular layer 32 and the arcuate layer 44 define a curved space extending longitudinally along the tubing 42. A viscoelastic material, here silicone gel 46, fills the space. In this embodiment there is no need for partition walls of the kind shown in the embodiment shown in FIG. 6. The tubing 42 is intended to be applied around the urethra, urine bladder, anus, colon or rectum so that the space with the protecting soft silicone gel 46 is located close to the urethra, urine bladder, anus, colon or rectum.
  • [0034]
    As taught by the embodiment of FIG. 7, in the composite structures shown in FIGS. 2 and 3, the soft silicone gel may alternatively be applied in a longitudinal space close to the inner side of the elongate composite structure 4 and 18, respectively, that is intended to contact the urethra, urine bladder, anus, colon or rectum.
  • [0035]
    In the same manner as described above in connection with the embodiment of FIG. 3, a layer of a fatigue resistant material, here polyurethane, may be applied on the outer tubular layer 32 of hard silicone of the tubing 30 and 42, respectively, along the side of the tubing 30 and 42, respectively, that is intended to contact the urethra, urine bladder, anus, colon or rectum, when the tubing 30 and 42, respectively, encircles the urethra, urine bladder, anus, colon or rectum.
  • [0036]
    [0036]FIG. 8 shows a cross-section of an elongate composite structure 48 of an embodiment of the invention, in which Teflon™ constitutes the self-supporting base material, which is formed to an inflatable tubing 50. Property improving means in the form of gas contained in a multiplicity of cavities 26 are formed in the base material to improve the flexibility of the tubing 50.
  • [0037]
    [0037]FIG. 9 shows a cross-section of a tubular composite structure of an embodiment of the invention, in which the self-supporting base material 52 is made of a polymer material suited for implantation, for example silicone or polyurethane. A property improving coating 54, for example made of Parylener™, Teflon™ or metal, is applied on the external surface or on both the external and internal surfaces of the tubular structure
  • [0038]
    [0038]FIG. 10 shows the same embodiment as FIG. 9, except that the base material comprises a layer 56 of polyurethane surrounded by a layer 58 of silicone.
  • [0039]
    [0039]FIG. 11 shows a cross-section of a mechanical constriction device of another embodiment of the invention, comprising a double walled tubing 60, an external wall 62 and an internal wall 64 spaced from the external wall 62, of a self-supporting base material of hard silicone. The tubing 60 has partition walls 66 dividing the space between the external and internal walls 62 and 64, respectively, of the tubing 60 into longitudinal cells 68, which are filled with a soft viscoelastic material, for example silicone gel. The internal wall 64 is coated with a friction reducing coating 70, for example made of Teflon™ or the like. A strong band 72 of nylon or the like slides in the tubing 60 on the friction reducing coating 70 to enable adjustment of the constriction device in the same manner as described above in connection with the embodiment according to FIGS. 1 and 2.
  • [0040]
    Although the present invention has been described in terms of particular embodiments, it is not intended that the invention be limited to those embodiments. Modifications of the embodiments within the spirit of the invention will be apparent to those skilled in the art. The scope of the invention is defined by the claims that follow.

Claims (82)

    What is claimed is:
  1. 1. An implantable constriction device for treating an incontinent patient, comprising an elongate composite structure adapted to constrict the urethra, urine bladder, anus, colon or rectum of the patient, wherein said elongate composite structure is composed of a base material making said composite structure self-supporting and property improving means for improving at least one physical property of said composite structure other than self-supporting properties.
  2. 2. An implantable constriction device according to claim 1, wherein said property improving means comprises a coating on said base material at least along a side of said elongate composite structure that is intended to contact the urethra, urine bladder, anus, colon or rectum, said coating having better aggressive body fluid resistant properties than said base material.
  3. 3. An implantable constriction device according to claim 2, wherein said coating is selected from the group consisting of a Teflon™, Parylene™, and a biocompatible metal coating.
  4. 4. An implantable constriction device according to claim 3, wherein the biocompatible metal coating is selected from the group consisting of gold, silver and titanium.
  5. 5. An implantable constriction device according to claim 2, wherein said property improving means comprises a core of a viscoelastic material covered with said self-supporting base material.
  6. 6. An implantable constriction device according to claim 5, wherein hard silicone constitutes said base material.
  7. 7. An implantable constriction device according to claim 5, wherein said viscoelastic material is selected from the group consisting of silicone gel, cellulose gel, and collagen gel.
  8. 8. An implantable constriction device according to claim 2, wherein said base material forms an inflatable tubing.
  9. 9. An implantable constriction device according to claim 8, wherein said tubing has an inner surface defining the interior of said tubing, and said coating covers said inner surface.
  10. 10. An implantable constriction device according to claim 8, wherein said coating is selected from the group consisting of Teflon™, Parylene™, and a biocompatible metal coating.
  11. 11. An implantable constriction device according to claim 10, wherein the biocompatible metal coating is selected from the group consisting of gold, silver and titanium.
  12. 12. An implantable constriction device according to claim 8, wherein hard silicone constitutes said base material.
  13. 13. An implantable constriction device according to claim 8, wherein said base material forms two coaxial tubular layers and said property improving means comprises a tubular intermediate layer of a viscoelastic material located between said coaxial tubular layers.
  14. 14. An implantable constriction device according to claim 13, wherein said viscoelastic material is selected from the group consisting of silicone gel, cellulose gel, and collagen gel.
  15. 15. An implantable constriction device according to claim 8, wherein said base material forms an outer tubular layer, an inner arcuate layer attached to said outer tubular layer, said outer and inner layers defining a curved space extending longitudinally along said tubing, and said property improving means comprises viscoelastic material filling said space.
  16. 16. An implantable constriction device according to claim 15, wherein said viscoelastic material is selected from the group consisting of silicone gel, cellulose gel, and collagen gel.
  17. 17. An implantable constriction device according to claim 1, wherein said property improving means comprises a coating on said base material at least along a side of said elongate composite structure that is intended to contact the urethra, urine bladder, anus, colon or rectum, said coating having better anti-friction properties than said base material.
  18. 18. An implantable constriction device according to claim 17, wherein said coating is selected from the group consisting of a Teflon™, Parylene™, and a biocompatible metal coating.
  19. 19. An implantable constriction device according to claim 18, wherein the biocompatible metal coating is selected from the group consisting of gold, silver and titanium.
  20. 20. An implantable constriction device according to claim 17, wherein said property improving means comprises a core of a viscoelastic material covered with said self-supporting base material.
  21. 21. An implantable constriction device according to claim 20, wherein hard silicone constitutes said base material.
  22. 22 An implantable constriction device according to claim 20, wherein said viscoelastic material is selected from the group consisting of silicone gel, cellulose gel, and collagen gel.
  23. 23. An implantable constriction device according to claim 17, wherein said base material forms an inflatable tubing.
  24. 24. An implantable constriction device according to claim 23, wherein said tubing has an inner surface defining the interior of said tubing, and said coating covers said inner surface.
  25. 25. An implantable constriction device according to claim 23, wherein said coating is selected from the group consisting of a Teflon™, Parylene™, and a biocompatible metal coating.
  26. 26. An implantable constriction device according to claim 25, wherein the biocompatible metal coating is selected from the group consisting of gold, silver and titanium.
  27. 27. An implantable constriction device according to claim 23, wherein hard silicone constitutes said base material.
  28. 28. An implantable constriction device according to claim 23, wherein said base material forms two coaxial tubular layers and said property improving means comprises a tubular intermediate layer of a viscoelastic material located between said coaxial tubular layers.
  29. 29. An implantable constriction device according to claim 28, wherein said viscoelastic material is selected from the group consisting of silicone gel, cellulose gel, and collagen gel.
  30. 30. An implantable constriction device according to claim 23, wherein said base material forms an outer tubular layer, an inner arcuate layer attached to said outer tubular layer, said outer and inner layers defining a curved space extending longitudinally along said tubing, and said property improving means comprises a viscoelastic material filling said space.
  31. 31. An implantable constriction device according to claim 30, wherein said viscoelastic material is selected from the group consisting of silicone gel, cellulose gel, and collagen gel.
  32. 32. An implantable constriction device according to claim 1, wherein said base material forms a first layer and said property improving means comprises a second layer applied on said first layer, said second layer being more fatigue resistant than said first layer.
  33. 33. An implantable constriction device according to claim 32, wherein said second layer covers said first layer of said base material along a side of said elongate composite structure that is intended to contact the urethra, urine bladder, anus, colon or rectum.
  34. 34. An implantable constriction device according to claim 32, wherein said second layer comprises a polyurethane layer.
  35. 35. An implantable constriction device according to claim 32, wherein said property improving means comprises a coating coated on said first layer and/or said second layer, said coating having better aggressive body fluid resistance properties and/or better anti-friction properties than said base material.
  36. 36. An implantable constriction device according to claim 35, wherein said coating is selected from the group consisting of Teflon™, Parylene™, and biocompatible metal coating.
  37. 37. An implantable constriction device according to claim 36, wherein the biocompatible metal coating is selected from the group consisting of gold, silver and titanium.
  38. 38. An implantable constriction device according to claim 32, wherein hard silicone constitutes said base material.
  39. 39. An implantable constriction device according to claim 32, wherein said first layer of said base material forms an inflatable tubing, and said second layer covers said base material within said tubing.
  40. 40. An implantable constriction device according to claim 1, wherein said base material forms an inflatable tubing and said property improving means comprises a liquid impermeable coating coated on said base material.
  41. 41. An implantable constriction device according to claim 40, wherein said tubing has an external surface of said base material and an internal surface of said base material defining the interior of said tubing, said coating being coated on said external surface and/or internal surface.
  42. 42. An implantable constriction device according to claim 40, wherein said coating is selected from the group consisting of Parylene™ and a biocompatible metal coating.
  43. 43. An implantable constriction device according to claim 42, wherein the biocompatible metal coating is selected from the group consisting of gold, silver and titanium.
  44. 44. An implantable constriction device according to claim 40, wherein hard silicone constitutes said base material.
  45. 45. An implantable constriction device according to claim 40, wherein said base material forms two coaxial tubular layers and said property improving means comprises a tubular intermediate layer of a viscoelastic material located between said coaxial tubular layers.
  46. 46. An implantable constriction device according to claim 44, wherein said viscoelastic material comprises silicone gel, cellulose gel or collagen gel.
  47. 47. An implantable constriction device according to claim 40, wherein said base material forms an outer tubular layer and an inner arcuate layer attached to said outer tubular layer, said outer and inner layers defining a curved space extending longitudinally along said tubing, and said property improving means comprises viscoelastic material filling said space.
  48. 48. An implantable constriction device according to claim 47, wherein said viscoelastic material is selected from the group consisting of silicone gel, cellulose gel, and collagen gel.
  49. 49. An implantable constriction device according to claim 1, wherein said property improving means comprises gas contained in a multiplicity of cavities formed in said base material to improve the flexibility of said composite structure.
  50. 50. An implantable constriction device according to claim 49, wherein said cavities are defined by net structures of said base material.
  51. 51. An implantable constriction device according to claim 49, wherein Teflon™ constitutes said base material.
  52. 52. An implantable constriction device according to claim 49, wherein said composite structure forms an inflatable tubing.
  53. 53. An implantable constriction device for treating an incontinent patient, comprising an elongate composite structure adapted to constrict the urethra, urine bladder, anus, colon or rectum of the patient, wherein the composite structure includes an elongate biocompatible self-supporting base material having surfaces exposed to aggressive body cells, when the constriction device is implanted in the patient, and a cell barrier coating coated on said surfaces to prevent body cells from breaking down the base material.
  54. 54. An implantable constriction device according to claim 53, wherein said barrier coating is selected from the group consisting of Parylene™ and a biocompatible metal coating.
  55. 55. An implantable constriction device according to claim 54, wherein the biocompatible metal coating is selected from the group consisting of gold, silver and titanium.
  56. 56. An implantable constriction device for treating an incontinent patient, comprising:
    elongate means for constricting the urethra, urine bladder, anus, colon or rectum of the patient, the constricting means including
    means for making the constricting means self-supporting, and
    means for improving at least one physical property of said constricting means other than self-supporting properties.
  57. 57. An implantable constriction device according to claim 56, wherein said property improving means improves the resistance to aggressive body cells or the anti-friction properties of said constricting means.
  58. 58. An implantable constriction device according to claim 57, wherein said property improving means comprises a coating on said self-supporting means at least along a side of said elongate constricting means that is intended to contact the urethra, urine bladder, anus, colon or rectum.
  59. 59. An implantable constriction device according to claim 58, wherein said coating is selected from the group consisting of a Teflon™, Parylene™, and a biocompatible metal coating.
  60. 60. An implantable constriction device according to claim 59, wherein the biocompatible metal coating is selected from the group consisting of gold, silver and titanium.
  61. 61. An implantable constriction device according to claim 56, wherein said property improving means improves the flexibility of said constricting means.
  62. 62. An implantable constriction device according to claim 61, wherein said property improving means comprises a core of a viscoelastic material covered with said self-supporting base material.
  63. 63. An implantable constriction device according to claim 62, wherein hard silicone constitutes said self-supporting means.
  64. 64. An implantable constriction device according to claim 62, wherein said viscoelastic material is selected from the group consisting of silicone gel, cellulose gel, and collagen gel.
  65. 65. An implantable constriction device according to claim 61, wherein said property improving means comprises gas contained in a multiplicity of cavities formed in said self-supporting means to improve the flexibility of said constricting means.
  66. 66. An implantable constriction device according to claim 65, wherein said cavities are defined by net structures of said self-supporting means.
  67. 67. An implantable constriction device according to claim 65, wherein Teflon™ constitutes said self-supporting means.
  68. 68. An implantable constriction device according to claim 56, wherein said property improving means improves the fatigue resistance of said constricting means.
  69. 69. An implantable constriction device according to claim 68, wherein said self-supporting means forms a first layer and said property improving means comprises a second layer applied on said first layer, said second layer being more fatigue resistant than said first layer.
  70. 70. An implantable constriction device according to claim 69, wherein said second layer covers said first layer of said self-supporting means along a side of said elongate constricting means that is intended to contact the urethra, urine bladder, anus, colon or rectum.
  71. 71. An implantable constriction device according to claim 69, wherein said second layer comprises a polyurethane layer.
  72. 72. An implantable constriction device according to claim 56, wherein said property improving means improves the liquid impermeability of said constricting means.
  73. 73. An implantable constriction device according to claim 72, wherein said self-supporting means forms an inflatable tubing and said property improving means comprises a liquid impermeable coating coated on said self-supporting means.
  74. 74. An implantable constriction device according to claim 73, wherein said tubing has an external surface of said self-supporting means and an internal surface of said self-supporting means defining the interior of said tubing, said coating being coated on said external surface and/or internal surface.
  75. 75. An implantable constriction device according to claim 73, wherein said coating is selected from the group consisting of Parylene™ and a biocompatible metal coating.
  76. 76. An implantable constriction device according to claim 75, wherein the biocompatible metal coating is selected from the group consisting of gold, silver and titanium.
  77. 77. An implantable constriction device according to claim 55, wherein hard silicon constitutes said self-supporting means.
  78. 78. An implantable constriction device for treating an incontinent patient, comprising:
    an elongate composite structure adapted to constrict the urethra, urine bladder, anus, colon or rectum of the patient,
    a base material of said composite structure making said composite structure self-supporting, and
    a coating on said base material at least along a side of said elongate composite structure that is intended to contact the urethra, urine bladder, anus, colon or rectum, said coating having better aggressive body fluid resistant properties than said base material.
  79. 79. An implantable constriction device for treating an incontinent patient, comprising:
    an elongate composite structure adapted to constrict the urethra, urine bladder, anus, colon or rectum of the patient,
    a base material of said composite structure making said composite structure self-supporting, and
    a coating on said base material at least along a side of said elongate composite structure that is intended to contact the urethra, urine bladder, anus, colon or rectum, said coating having better anti-friction properties than said base material.
  80. 80. An implantable constriction device for treating an incontinent patient, comprising:
    an elongate composite structure adapted to constrict the urethra, urine bladder, anus, colon or rectum of the patient,
    a base material of said composite structure making said composite structure self-supporting, said base material forming a first layer, and
    a second layer applied on said first layer, said second layer being more fatigue resistant than said first layer.
  81. 81. An implantable constriction device for treating an incontinent patient, comprising:
    an elongate composite structure adapted to constrict the urethra, urine bladder, anus, colon or rectum of the patient,
    a liquid semi-permeable base material of said composite structure forming an inflatable tubing and making said composite structure self-supporting, and
    a liquid impermeable coating coated on said base material.
  82. 82. An implantable constriction device for treating an incontinent patient, comprising:
    an elongate composite structure adapted to constrict the urethra, urine bladder, anus, colon or rectum of the patient, and
    a base material of said composite structure making said composite structure self-supporting, said base material forming a multiplicity of gas-containing cavities to improve the flexibility of said composite structure.
US10463873 2002-07-29 2003-06-18 Multi-material incontinence treatment constriction device Abandoned US20040034275A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US39882402 true 2002-07-29 2002-07-29
US10463873 US20040034275A1 (en) 2002-07-29 2003-06-18 Multi-material incontinence treatment constriction device

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10463873 US20040034275A1 (en) 2002-07-29 2003-06-18 Multi-material incontinence treatment constriction device
US11889756 US9278158B2 (en) 2002-07-29 2007-08-16 Multi-material incontinence treatment construction device

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11889756 Continuation US9278158B2 (en) 2002-07-29 2007-08-16 Multi-material incontinence treatment construction device

Publications (1)

Publication Number Publication Date
US20040034275A1 true true US20040034275A1 (en) 2004-02-19

Family

ID=31188496

Family Applications (2)

Application Number Title Priority Date Filing Date
US10463873 Abandoned US20040034275A1 (en) 2002-07-29 2003-06-18 Multi-material incontinence treatment constriction device
US11889756 Active US9278158B2 (en) 2002-07-29 2007-08-16 Multi-material incontinence treatment construction device

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11889756 Active US9278158B2 (en) 2002-07-29 2007-08-16 Multi-material incontinence treatment construction device

Country Status (4)

Country Link
US (2) US20040034275A1 (en)
EP (1) EP1539054B1 (en)
CA (1) CA2493479C (en)
WO (1) WO2004010908A1 (en)

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030125605A1 (en) * 2000-02-11 2003-07-03 Peter Forsell Controlled impotence treatment
US20060111791A1 (en) * 2002-07-29 2006-05-25 Peter Forsell Durable implant
US20070015959A1 (en) * 2000-02-14 2007-01-18 Obtech Medical Ag Male impotence prosthesis apparatus with wireless energy supply
US20080004487A1 (en) * 2006-06-29 2008-01-03 Haverfield Maxwell E Method of treating anal incontinence
US20080045783A1 (en) * 2002-07-29 2008-02-21 Peter Forsell Multi-material incontinence treatment construction device
US20080183271A1 (en) * 2007-01-31 2008-07-31 Abbott Laboratories Compliant crimping sheath
US20080200965A1 (en) * 2003-01-31 2008-08-21 Potencia Medical Ag Electrically operable incontinence treatment apparatus
US20080200753A1 (en) * 2003-01-31 2008-08-21 Potencia Medical Ag Electrically operable incontinence treatment apparatus
WO2009006100A2 (en) * 2007-06-28 2009-01-08 Wilson-Cook Medical Inc. Sphincterotome cutting wire improvement
US20090054725A1 (en) * 2000-02-10 2009-02-26 Obtech Medical Ag Mechanical impotence treatment apparatus
US20090156891A1 (en) * 2007-12-12 2009-06-18 Ams Research Corporation Prolapse and Perineal Repair Concepts
US20090240100A1 (en) * 2007-10-11 2009-09-24 Milux Holding S.A. Schneider, Luxembourg Method for controlling flow of intestinal contents in a patient's intestines
US20100145139A1 (en) * 2000-02-10 2010-06-10 Obtech Medical Ag Controlled urinary incontinence treatment
US20100305395A1 (en) * 2009-05-28 2010-12-02 Contine Corporation Correction of stress urinary incontinence
US20100312164A1 (en) * 2008-01-28 2010-12-09 Peter Forsell Implantable drainage device
US20100331616A1 (en) * 2008-10-10 2010-12-30 Peter Forsell Method and instrument for treating obesity
US20110040143A1 (en) * 2000-02-11 2011-02-17 Obtech Medical Ag Impotence treatment apparatus with energy transforming means
US20110066254A1 (en) * 2007-10-11 2011-03-17 Peter Forsell Method for controlling flow in a bodily organ
US20110082328A1 (en) * 2007-01-03 2011-04-07 Christian Gozzi Methods for installing sling to treat fecal incontinence, and related devices
US20110087337A1 (en) * 2007-10-11 2011-04-14 Peter Forsell Apparatus for controlling flow in a bodily organ
US20110196485A1 (en) * 2008-10-10 2011-08-11 Peter Forsell Heart help device, system, and method
US20110202041A1 (en) * 2008-10-10 2011-08-18 Milux Holding Sa Fastening means for implantable medical control assembly
US20110202131A1 (en) * 2008-10-10 2011-08-18 Milux Holding Sa Heart help device, system, and method
US8096939B2 (en) 2000-02-10 2012-01-17 Obtech Medical Ag Urinary incontinence treatment with wireless energy supply
US8096938B2 (en) 1999-08-12 2012-01-17 Obtech Medical Ag Controlled anal incontinence disease treatment
US8126558B2 (en) 2000-02-14 2012-02-28 Obtech Medical Ag Controlled penile prosthesis
US8313423B2 (en) 2000-02-14 2012-11-20 Peter Forsell Hydraulic anal incontinence treatment
US8545384B2 (en) 1999-08-12 2013-10-01 Obtech Medical Ag Anal incontinence disease treatment with controlled wireless energy supply
US8600510B2 (en) 2008-10-10 2013-12-03 Milux Holding Sa Apparatus, system and operation method for the treatment of female sexual dysfunction
US8734318B2 (en) 2000-02-11 2014-05-27 Obtech Medical Ag Mechanical anal incontinence
US8764627B2 (en) 2000-02-14 2014-07-01 Obtech Medical Ag Penile prosthesis
US8795153B2 (en) 2007-10-11 2014-08-05 Peter Forsell Method for treating female sexual dysfunction
US8874215B2 (en) 2008-10-10 2014-10-28 Peter Forsell System, an apparatus, and a method for treating a sexual dysfunctional female patient
US20160113754A1 (en) * 2013-05-21 2016-04-28 Uromems Implantable occlusion system comprising a device for detecting atrophy of a natural conduit
US9949812B2 (en) 2009-07-17 2018-04-24 Peter Forsell Vaginal operation method for the treatment of anal incontinence in women

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040133219A1 (en) * 2002-07-29 2004-07-08 Peter Forsell Multi-material constriction device for forming stoma opening
US20060094926A1 (en) * 2002-07-29 2006-05-04 Peter Forsell Multi-material penis constriction device
FR2912659B1 (en) * 2007-02-21 2011-09-09 Cie Euro Etude Rech Paroscopie implantable device and method of manufacture corresponding
US20110015473A1 (en) * 2009-07-17 2011-01-20 Teslux Holdings S.A. Vaginal operation method for the treatment of urinary incontinence in women
US8932200B2 (en) * 2010-05-24 2015-01-13 Ronald L. Cotner Device for the treatment of urinary incontinence
US9808329B2 (en) 2015-01-12 2017-11-07 Ronald L. Cotner Device for preventing overexpansion of bodily organ

Family Cites Families (159)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2060913A (en) 1934-07-07 1936-11-17 Western Electric Co Electrical conductor
US2795641A (en) * 1953-12-03 1957-06-11 Rowell Ross Fredrick Cord supporting coil
US3209081A (en) 1961-10-02 1965-09-28 Behrman A Ducote Subcutaneously implanted electronic device
US3366975A (en) 1965-06-04 1968-02-06 William J. Pangman Compound prosthesis
US3731679A (en) * 1970-10-19 1973-05-08 Sherwood Medical Ind Inc Infusion system
US3750194A (en) 1971-03-16 1973-08-07 Fairchild Industries Apparatus and method for reversibly closing a natural or implanted body passage
FR2138333B1 (en) 1971-05-24 1974-03-08 Rhone Poulenc Sa
US3817237A (en) * 1972-08-24 1974-06-18 Medtronic Inc Regulatory apparatus
US3875928A (en) * 1973-08-16 1975-04-08 Angelchik Jean P Method for maintaining the reduction of a sliding esophageal hiatal hernia
US3954102A (en) * 1974-07-19 1976-05-04 American Medical Systems, Inc. Penile erection system and methods of implanting and using same
US4026305A (en) * 1975-06-26 1977-05-31 Research Corporation Low current telemetry system for cardiac pacers
US4009711A (en) * 1976-03-17 1977-03-01 Uson Aurelio C Penile prosthesis for the management of erectile impotence
US4243306A (en) * 1978-05-30 1981-01-06 Bononi Walter H Pad device
US4246893A (en) * 1978-07-05 1981-01-27 Daniel Berson Inflatable gastric device for treating obesity
US4201202A (en) * 1978-09-25 1980-05-06 Medical Engineering Corp. Penile implant
US4235222A (en) 1978-10-19 1980-11-25 Istrate Ionescu Heat-responsive alignment system and solar collection device
US4820302A (en) * 1982-04-22 1989-04-11 Sterling Drug Inc. Bio compatible and blood compatible materials and methods
US4318396A (en) * 1980-05-15 1982-03-09 Medical Engineering Corporation Penile prosthesis
US4342308A (en) 1980-10-02 1982-08-03 Medical Engineering Corporation Penile erectile system
US4298998A (en) 1980-12-08 1981-11-10 Naficy Sadeque S Breast prosthesis with biologically absorbable outer container
US4412530A (en) 1981-09-21 1983-11-01 American Medical Systems, Inc. Dual-mode valve pressure regulating system
US4369771A (en) * 1981-09-24 1983-01-25 Medical Engineering Corporation Penile erectile system
US4424807A (en) * 1981-10-20 1984-01-10 Evans Sr Alvin S Penile implant
US4428365A (en) * 1982-03-01 1984-01-31 Hakky Said I Anti-incontinent prostheses
US4480642A (en) 1982-07-26 1984-11-06 Health Products Research, Inc. Dilation device for the cervix
US4542753A (en) 1982-12-22 1985-09-24 Biosonics, Inc. Apparatus and method for stimulating penile erectile tissue
US4592355A (en) * 1983-01-28 1986-06-03 Eliahu Antebi Process for tying live tissue and an instrument for performing the tying operation
US4517967A (en) * 1983-04-18 1985-05-21 Dacomed Corporation Penile prosthesis
US4491461A (en) * 1983-05-17 1985-01-01 Hoekstra Irenus A Method of desulfurization of flue gases
US4550720A (en) 1983-11-15 1985-11-05 Medical Engineering Corporation Capacitance device for medical implant
US4556050A (en) * 1984-05-02 1985-12-03 Hodgson Darel E Artificial sphincter including a shape memory member
US4559930A (en) 1984-05-07 1985-12-24 Cobiski John F Thoracic bench
WO1986001395A1 (en) * 1984-09-05 1986-03-13 Intra Optics Laboratories Pty. Ltd. Control of blood flow
US4664100A (en) * 1984-11-19 1987-05-12 Rudloff David A C Penile implant
US4756949A (en) * 1984-11-29 1988-07-12 Kimberly-Clark Corporation Method for producing pad structures with viscoelastic cores and article so made
US4602621A (en) * 1984-12-18 1986-07-29 Hakky Said I Manually actuated, self contained penile implant
WO1986004067A1 (en) * 1984-12-27 1986-07-17 Suntory Limited Method for purifying an interferon
EP0200286A3 (en) 1985-02-28 1987-01-14 Quotidian No. 100 Pty. Limited Control of blood flow
US4679560A (en) * 1985-04-02 1987-07-14 Board Of Trustees Of The Leland Stanford Junior University Wide band inductive transdermal power and data link
US4592339A (en) * 1985-06-12 1986-06-03 Mentor Corporation Gastric banding device
US4696288A (en) 1985-08-14 1987-09-29 Kuzmak Lubomyr I Calibrating apparatus and method of using same for gastric banding surgery
US4723538A (en) * 1986-10-16 1988-02-09 Stewart Edward T Penile constrictor ring
US4711231A (en) 1986-11-03 1987-12-08 Aaron N. Finegold Implantable prosthesis system
US4771780A (en) 1987-01-15 1988-09-20 Siemens-Pacesetter, Inc. Rate-responsive pacemaker having digital motion sensor
US4829990A (en) * 1987-06-25 1989-05-16 Thueroff Joachim Implantable hydraulic penile erector
US4846794A (en) * 1987-08-13 1989-07-11 The Cleveland Clinic Foundation Coiled tubing for intravenous and intra-arterial applications
US4955907A (en) 1987-12-22 1990-09-11 Ledergerber Walter J Implantable prosthetic device
US4942668A (en) * 1988-05-11 1990-07-24 Zircon International, Inc. Digital inclinometer
US5012822A (en) * 1988-10-11 1991-05-07 Schwarz Gerald R Method for controlling urinary incontinence
US4982731A (en) * 1988-10-26 1991-01-08 The Regents Of The University Of California Implantable system and method for augmenting penile erection
US5062416A (en) 1988-12-01 1991-11-05 Stucks Albert A Penile erection system
US4941461A (en) * 1989-09-05 1990-07-17 Fischell Robert Electrically actuated inflatable penile erection device
US5042084A (en) 1989-09-07 1991-08-20 Cochlear Pty. Limited Three wire system for Cochlear implant processor
US4958630A (en) 1989-10-06 1990-09-25 Advanced Surgical Intervention, Inc. Method and apparatus for treating impotence
US5067491A (en) 1989-12-08 1991-11-26 Becton, Dickinson And Company Barrier coating on blood contacting devices
US5074868A (en) 1990-08-03 1991-12-24 Inamed Development Company Reversible stoma-adjustable gastric band
US5226429A (en) * 1991-06-20 1993-07-13 Inamed Development Co. Laparoscopic gastric band and method
US5160338A (en) 1991-11-13 1992-11-03 Inamed Development Co. Device for removing implantable articles
US5304206A (en) * 1991-11-18 1994-04-19 Cyberonics, Inc. Activation techniques for implantable medical device
FR2688693A1 (en) 1992-03-19 1993-09-24 Ferriere Xavier Artificial sphincter, especially urethral (urinary) sphincter
FR2692777A1 (en) 1992-06-26 1993-12-31 Alfieri Patrick Remote control unit for implant esp. artificial sphincter in human body - uses oscillator, amplifier, and transmitting antenna to send energy to tuned receiving antenna on implant
US5449368A (en) 1993-02-18 1995-09-12 Kuzmak; Lubomyr I. Laparoscopic adjustable gastric banding device and method for implantation and removal thereof
US5601604A (en) 1993-05-27 1997-02-11 Inamed Development Co. Universal gastric band
US5437605A (en) 1993-05-27 1995-08-01 Helmy; Ali M. Remote controllable penile prosthetic system
US5518504A (en) * 1993-12-28 1996-05-21 American Medical Systems, Inc. Implantable sphincter system utilizing lifting means
FR2717069B1 (en) 1994-03-14 1996-04-26 Braun Celsa Sa Medical prosthesis, such as a blood filter, provided with a coating limiting the adhesion or cell development.
US5454840A (en) 1994-04-05 1995-10-03 Krakovsky; Alexander A. Potency package
CA2147813A1 (en) 1994-04-28 1995-10-29 Richard Dixon Intravascular prosthesis with anti-thrombogenic coating
JPH07328050A (en) * 1994-06-10 1995-12-19 Siegel:Kk Shaping pad and manufacture thereof
US5453079A (en) 1994-06-15 1995-09-26 Schwaninger; Claude L. Blood flow valve for treatment of male sexual impotence
JPH10502547A (en) * 1994-07-11 1998-03-10 デーコムド コーポレーション Tube blockage prosthetics
US5509888A (en) * 1994-07-26 1996-04-23 Conceptek Corporation Controller valve device and method
US5540731A (en) * 1994-09-21 1996-07-30 Medtronic, Inc. Method and apparatus for pressure detecting and treating obstructive airway disorders
DE4435602C2 (en) 1994-10-05 1998-07-16 Gunter Preis Method and apparatus for the supply of implanted measuring, control and regulation systems with energy and for bidirectional data transfer
US5669930A (en) 1994-12-08 1997-09-23 Fuji Systems Corporation Stent for intracorporeal retention
US5591217A (en) * 1995-01-04 1997-01-07 Plexus, Inc. Implantable stimulator with replenishable, high value capacitive power source and method therefor
DE19511998A1 (en) 1995-03-31 1996-10-02 Eska Medical Gmbh & Co Controller for discharge of urine from urethra
JPH08336069A (en) * 1995-04-13 1996-12-17 Eastman Kodak Co Electronic still camera
CA2178541C (en) * 1995-06-07 2009-11-24 Neal E. Fearnot Implantable medical device
US5609629A (en) 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
KR100373772B1 (en) 1995-07-31 2003-02-13 심영택 Treatment apparatus for erectile disorder
US5771903A (en) * 1995-09-22 1998-06-30 Kirk Promotions Limited Surgical method for reducing the food intake of a patient
US6102922A (en) 1995-09-22 2000-08-15 Kirk Promotions Limited Surgical method and device for reducing the food intake of patient
US5855613A (en) * 1995-10-13 1999-01-05 Islet Sheet Medical, Inc. Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change
US6287315B1 (en) 1995-10-30 2001-09-11 World Medical Manufacturing Corporation Apparatus for delivering an endoluminal prosthesis
US5578069A (en) 1995-12-06 1996-11-26 Vnetritex, Inc. Electrode deployment mechanism and method using artificial muscle
WO1997041799A1 (en) 1996-05-05 1997-11-13 Influence Medical Technologies Ltd. Implantable pump and prosthetic devices
US5772903A (en) * 1996-09-27 1998-06-30 Hirsch; Gregory Tapered capillary optics
DE69724386D1 (en) 1996-10-30 2003-10-02 Nihon Kohden Corp Stimulation device for the prevention of urinary incontinence
US5749909A (en) * 1996-11-07 1998-05-12 Sulzer Intermedics Inc. Transcutaneous energy coupling using piezoelectric device
WO1998037926A1 (en) * 1997-02-26 1998-09-03 Alfred E. Mann Foundation For Scientific Research Battery-powered patient implantable device
US5938669A (en) 1997-05-07 1999-08-17 Klasamed S.A. Adjustable gastric banding device for contracting a patient's stomach
US6135945A (en) 1997-08-04 2000-10-24 Sultan; Hashem Anti-incontinence device
US5971967A (en) * 1997-08-19 1999-10-26 Abbeymoor Medical, Inc. Urethral device with anchoring system
US5938584A (en) 1997-11-14 1999-08-17 Cybernetic Medical Systems Corporation Cavernous nerve stimulation device
ES2149091B1 (en) 1998-03-10 2001-05-16 Gil Vernet Vila Jose Maria Device for fastening and height adjustable support of internal anatomical organs.
US6319191B1 (en) 1998-03-26 2001-11-20 Precision Medical Devices, Inc. Implantable body fluid flow control device
US20020099438A1 (en) * 1998-04-15 2002-07-25 Furst Joseph G. Irradiated stent coating
US5910149A (en) * 1998-04-29 1999-06-08 Kuzmak; Lubomyr I. Non-slipping gastric band
US6074341A (en) * 1998-06-09 2000-06-13 Timm Medical Technologies, Inc. Vessel occlusive apparatus and method
US6460543B1 (en) 1998-08-13 2002-10-08 Obtech Medical Ag Non-injection port food intake restriction device
US6067991A (en) * 1998-08-13 2000-05-30 Forsell; Peter Mechanical food intake restriction device
US6210347B1 (en) * 1998-08-13 2001-04-03 Peter Forsell Remote control food intake restriction device
FR2783153B1 (en) 1998-09-14 2000-12-01 Jerome Dargent gastric constriction device
WO2000015140A1 (en) 1998-09-15 2000-03-23 Infinite Biomedical Technologies, Incorporated Intraurethral continent prothesis
JP4559630B2 (en) 1998-11-25 2010-10-13 ユナイテッド ステイツ サージカル コーポレイションUnited States Surgical Corporation Biopsy system
ES2150881B1 (en) 1999-02-11 2002-02-16 Univ Madrid Complutense External magnetic valve drive for an intraurethral artificial urinary sphincter.
US6162238A (en) 1999-02-24 2000-12-19 Aaron V. Kaplan Apparatus and methods for control of body lumens
US6516227B1 (en) * 1999-07-27 2003-02-04 Advanced Bionics Corporation Rechargeable spinal cord stimulator system
FR2797181B1 (en) 1999-08-05 2002-05-03 Richard Cancel Gastric band device remote to form a restricted stoma opening in the stomach
US6453907B1 (en) 1999-08-12 2002-09-24 Obtech Medical Ag Food intake restriction with energy transfer device
US6454701B1 (en) 1999-08-12 2002-09-24 Obtech Medical Ag Heartburn and reflux disease treatment apparatus with energy transfer device
US6454698B1 (en) 1999-08-12 2002-09-24 Obtech Medical Ag Anal incontinence treatment with energy transfer device
US6464628B1 (en) * 1999-08-12 2002-10-15 Obtech Medical Ag Mechanical anal incontinence
US6503189B1 (en) 1999-08-12 2003-01-07 Obtech Medical Ag Controlled anal incontinence disease treatment
ES2338208T3 (en) 1999-08-12 2010-05-05 Potencia Medical Ag Apparatus for forming a stoma opening.
FR2802798B1 (en) * 1999-12-22 2002-02-01 Promedon S A Strap pad for treatment of urinary incontinence
US6454700B1 (en) 2000-02-09 2002-09-24 Obtech Medical Ag Heartburn and reflux disease treatment apparatus with wireless energy supply
US6470892B1 (en) 2000-02-10 2002-10-29 Obtech Medical Ag Mechanical heartburn and reflux treatment
US6463935B1 (en) 2000-02-10 2002-10-15 Obtech Medical Ag Controlled heartburn and reflux disease treatment
US6471635B1 (en) 2000-02-10 2002-10-29 Obtech Medical Ag Anal incontinence disease treatment with controlled wireless energy supply
EP1253879B1 (en) * 2000-02-10 2005-10-12 Potencia Medical AG Urinary incontinence treatment with wireless energy supply
DE60133592D1 (en) * 2000-02-10 2008-05-21 Potencia Medical Ag Mechanical device for impotence treatment
EP1253880B1 (en) * 2000-02-10 2005-09-14 Potencia Medical AG Controlled urinary incontinence treatment
US7931582B2 (en) * 2000-02-11 2011-04-26 Obtech Medical Ag Controlled impotence treatment
CN101138528B (en) * 2000-02-11 2015-02-25 波坦蒂卡股份公司 Impotence treatment apparatus with energy transforming means
US6450946B1 (en) 2000-02-11 2002-09-17 Obtech Medical Ag Food intake restriction with wireless energy transfer
US6454699B1 (en) * 2000-02-11 2002-09-24 Obtech Medical Ag Food intake restriction with controlled wireless energy supply
DE60125351T2 (en) * 2000-02-11 2007-05-16 Potencia Medical Ag Urinary incontinence treatment device
US6482145B1 (en) * 2000-02-14 2002-11-19 Obtech Medical Ag Hydraulic anal incontinence treatment
US6953429B2 (en) 2000-02-14 2005-10-11 Obtech Medical Ag Hydraulic urinary incontinence treatment apparatus
EP1255513B1 (en) * 2000-02-14 2005-05-25 Potencia Medical AG Penile prosthesis
DE60119081D1 (en) * 2000-02-14 2006-06-01 Potencia Medical Ag Male impotentzprothesevorrichtung with wireless energy supply
DE60116599D1 (en) * 2000-02-14 2006-04-06 Potencia Medical Ag Baar An apparatus for treating male impotence
US20030100929A1 (en) 2000-02-14 2003-05-29 Peter Forsell Controlled penile prosthesis
US6475136B1 (en) 2000-02-14 2002-11-05 Obtech Medical Ag Hydraulic heartburn and reflux treatment
DE20004915U1 (en) 2000-02-20 2001-07-05 Ruebben Alexander Magnetic resonance compatible implants made of a gold-copper alloy
US6558315B1 (en) 2000-03-15 2003-05-06 Ams Research Corporation Parylene-coated components for inflatable penile prosthesis
US6572627B2 (en) * 2001-01-08 2003-06-03 Shlomo Gabbay System to inhibit and/or control expansion of anatomical features
US20020133225A1 (en) 2001-03-13 2002-09-19 Gordon Lucas S. Methods and apparatuses for delivering a medical agent to a medical implant
US6586048B2 (en) 2001-04-05 2003-07-01 Honeywell International Inc. Method for depositing a barrier coating on a polymeric substrate and composition comprising said barrier coating
US6915165B2 (en) * 2001-06-28 2005-07-05 Obtech Medical Ag Intestine dysfunction treatment apparatus
JP4883852B2 (en) 2001-07-30 2012-02-22 日東電工株式会社 Heating method of removing chips cut pieces from the heat-peelable pressure-sensitive adhesive sheet
US6913626B2 (en) * 2001-08-14 2005-07-05 Mcghan Jim J. Medical implant having bioabsorbable textured surface
US7179283B2 (en) * 2001-11-02 2007-02-20 Scimed Life Systems, Inc. Vapor deposition process for producing a stent-graft and a stent-graft produced therefrom
JP4691445B2 (en) * 2002-07-22 2011-06-01 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company Patch-like injection device
WO2004011051A1 (en) * 2002-07-29 2004-02-05 Potencia Medical Ag Durable implant
US20060094926A1 (en) * 2002-07-29 2006-05-04 Peter Forsell Multi-material penis constriction device
US20040034275A1 (en) * 2002-07-29 2004-02-19 Peter Forsell Multi-material incontinence treatment constriction device
US20040133219A1 (en) * 2002-07-29 2004-07-08 Peter Forsell Multi-material constriction device for forming stoma opening
EP1539294B1 (en) 2002-08-02 2011-01-26 Prosthesica AG Apparatus for distributing liquid in a patient's body
EP1587455B8 (en) * 2003-01-31 2007-05-02 Instant Communication AG Electrically operable impotence treatment apparatus
WO2004066887A1 (en) 2003-01-31 2004-08-12 Potencia Medical Ag Incontinence treatment apparatus with connection device
DE60312564D1 (en) * 2003-01-31 2007-04-26 Potencia Medical Ag Electrically operable device for treating incontinence
EP1587464B1 (en) * 2003-01-31 2007-08-29 Potencia Medical AG Careful incontinence treatment apparatus
EP1587456B1 (en) * 2003-01-31 2007-08-29 Potencia Medical AG Careful impotence treatment apparatus
US7407481B2 (en) 2003-01-31 2008-08-05 Peter Forsell Impotence treatment apparatus with connection device
US9555241B2 (en) 2007-10-11 2017-01-31 Peter Forsell Method of obtaining male contraception
US8696543B2 (en) 2007-10-11 2014-04-15 Kirk Promotion Ltd. Method for controlling flow of intestinal contents in a patient's intestines

Cited By (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8545384B2 (en) 1999-08-12 2013-10-01 Obtech Medical Ag Anal incontinence disease treatment with controlled wireless energy supply
US8096938B2 (en) 1999-08-12 2012-01-17 Obtech Medical Ag Controlled anal incontinence disease treatment
US20090054725A1 (en) * 2000-02-10 2009-02-26 Obtech Medical Ag Mechanical impotence treatment apparatus
US8287444B2 (en) 2000-02-10 2012-10-16 Obtech Medical Ag Mechanical impotence treatment apparatus
US8556796B2 (en) 2000-02-10 2013-10-15 Obtech Medical Ag Controlled urinary incontinence treatment
US8602966B2 (en) 2000-02-10 2013-12-10 Obtech Medical, AG Mechanical impotence treatment apparatus
US20100145139A1 (en) * 2000-02-10 2010-06-10 Obtech Medical Ag Controlled urinary incontinence treatment
US8096939B2 (en) 2000-02-10 2012-01-17 Obtech Medical Ag Urinary incontinence treatment with wireless energy supply
US8734318B2 (en) 2000-02-11 2014-05-27 Obtech Medical Ag Mechanical anal incontinence
US7931582B2 (en) 2000-02-11 2011-04-26 Obtech Medical Ag Controlled impotence treatment
US8290594B2 (en) 2000-02-11 2012-10-16 Obtech Medical Ag Impotence treatment apparatus with energy transforming means
US20030125605A1 (en) * 2000-02-11 2003-07-03 Peter Forsell Controlled impotence treatment
US20110040143A1 (en) * 2000-02-11 2011-02-17 Obtech Medical Ag Impotence treatment apparatus with energy transforming means
US8313423B2 (en) 2000-02-14 2012-11-20 Peter Forsell Hydraulic anal incontinence treatment
US20070015959A1 (en) * 2000-02-14 2007-01-18 Obtech Medical Ag Male impotence prosthesis apparatus with wireless energy supply
US8126558B2 (en) 2000-02-14 2012-02-28 Obtech Medical Ag Controlled penile prosthesis
US8678997B2 (en) 2000-02-14 2014-03-25 Obtech Medical Ag Male impotence prosthesis apparatus with wireless energy supply
US8764627B2 (en) 2000-02-14 2014-07-01 Obtech Medical Ag Penile prosthesis
US20080045783A1 (en) * 2002-07-29 2008-02-21 Peter Forsell Multi-material incontinence treatment construction device
US20060111791A1 (en) * 2002-07-29 2006-05-25 Peter Forsell Durable implant
US9427301B2 (en) 2002-07-29 2016-08-30 Peter Forsell Durable implant
US9278158B2 (en) 2002-07-29 2016-03-08 Peter Forsell Multi-material incontinence treatment construction device
US20080200753A1 (en) * 2003-01-31 2008-08-21 Potencia Medical Ag Electrically operable incontinence treatment apparatus
US20080200965A1 (en) * 2003-01-31 2008-08-21 Potencia Medical Ag Electrically operable incontinence treatment apparatus
US8801593B2 (en) 2006-06-29 2014-08-12 Ams Research Corporation Method of treating anal incontinence
US7828715B2 (en) 2006-06-29 2010-11-09 Ams Research Corporation Method of treating anal incontinence
US20080004487A1 (en) * 2006-06-29 2008-01-03 Haverfield Maxwell E Method of treating anal incontinence
US20110060180A1 (en) * 2006-06-29 2011-03-10 Haverfield Maxwell E Method of treating anal incontinence
US8371998B2 (en) 2006-06-29 2013-02-12 American Research Corporation Method of treating anal incontinence
US20110082328A1 (en) * 2007-01-03 2011-04-07 Christian Gozzi Methods for installing sling to treat fecal incontinence, and related devices
US20080183271A1 (en) * 2007-01-31 2008-07-31 Abbott Laboratories Compliant crimping sheath
WO2009006100A3 (en) * 2007-06-28 2009-12-23 Wilson-Cook Medical Inc. Sphincterotome cutting wire improvement
WO2009006100A2 (en) * 2007-06-28 2009-01-08 Wilson-Cook Medical Inc. Sphincterotome cutting wire improvement
US8696543B2 (en) 2007-10-11 2014-04-15 Kirk Promotion Ltd. Method for controlling flow of intestinal contents in a patient's intestines
US20110066254A1 (en) * 2007-10-11 2011-03-17 Peter Forsell Method for controlling flow in a bodily organ
US8992409B2 (en) 2007-10-11 2015-03-31 Peter Forsell Method for controlling flow in a bodily organ
US20110087337A1 (en) * 2007-10-11 2011-04-14 Peter Forsell Apparatus for controlling flow in a bodily organ
US20090240100A1 (en) * 2007-10-11 2009-09-24 Milux Holding S.A. Schneider, Luxembourg Method for controlling flow of intestinal contents in a patient's intestines
US9662117B2 (en) 2007-10-11 2017-05-30 Peter Forsell Apparatus for controlling flow in a bodily organ
US8795153B2 (en) 2007-10-11 2014-08-05 Peter Forsell Method for treating female sexual dysfunction
US20090156891A1 (en) * 2007-12-12 2009-06-18 Ams Research Corporation Prolapse and Perineal Repair Concepts
US9694165B2 (en) * 2008-01-28 2017-07-04 Peter Mats Forsell Implantable drainage device
US8961448B2 (en) 2008-01-28 2015-02-24 Peter Forsell Implantable drainage device
US20100312164A1 (en) * 2008-01-28 2010-12-09 Peter Forsell Implantable drainage device
US20150157836A1 (en) * 2008-01-28 2015-06-11 Peter Mats Forsell Implantable drainage device
US8636809B2 (en) 2008-01-29 2014-01-28 Milux Holding Sa Device for treating obesity
US20100332000A1 (en) * 2008-01-29 2010-12-30 Peter Forsell Device for treating obesity
US9060771B2 (en) 2008-01-29 2015-06-23 Peter Forsell Method and instrument for treating obesity
US8696745B2 (en) 2008-10-10 2014-04-15 Kirk Promotion Ltd. Heart help device, system, and method
US20100331616A1 (en) * 2008-10-10 2010-12-30 Peter Forsell Method and instrument for treating obesity
US8600510B2 (en) 2008-10-10 2013-12-03 Milux Holding Sa Apparatus, system and operation method for the treatment of female sexual dysfunction
US9526649B2 (en) 2008-10-10 2016-12-27 Peter Forsell Method and instrument for treating obesity
US8874215B2 (en) 2008-10-10 2014-10-28 Peter Forsell System, an apparatus, and a method for treating a sexual dysfunctional female patient
US20110196485A1 (en) * 2008-10-10 2011-08-11 Peter Forsell Heart help device, system, and method
US20110202041A1 (en) * 2008-10-10 2011-08-18 Milux Holding Sa Fastening means for implantable medical control assembly
US9370656B2 (en) 2008-10-10 2016-06-21 Peter Forsell System, an apparatus, and a method for treating a sexual dysfunctional female patient
US20110202131A1 (en) * 2008-10-10 2011-08-18 Milux Holding Sa Heart help device, system, and method
US8509894B2 (en) 2008-10-10 2013-08-13 Milux Holding Sa Heart help device, system, and method
US9072907B2 (en) 2008-10-10 2015-07-07 Peter Forsell Heart help device, system, and method
US20110224787A1 (en) * 2008-10-10 2011-09-15 Milux Holding Sa Heart help device, system, and method
RU2548825C2 (en) * 2009-05-28 2015-04-20 Контайн Корпорейшн Correction of stress urinary incontinence
US20100305395A1 (en) * 2009-05-28 2010-12-02 Contine Corporation Correction of stress urinary incontinence
WO2010138892A3 (en) * 2009-05-28 2011-04-21 Contine Corporation Correction of stress urinary incontinence
US7981021B2 (en) 2009-05-28 2011-07-19 Contine Corporation Correction of stress urinary incontinence
US8323176B2 (en) 2009-05-28 2012-12-04 Contine Corporation Correction of stress urinary incontinence
US9949812B2 (en) 2009-07-17 2018-04-24 Peter Forsell Vaginal operation method for the treatment of anal incontinence in women
US20160113754A1 (en) * 2013-05-21 2016-04-28 Uromems Implantable occlusion system comprising a device for detecting atrophy of a natural conduit

Also Published As

Publication number Publication date Type
CA2493479A1 (en) 2004-02-05 application
EP1539054A1 (en) 2005-06-15 application
EP1539054B1 (en) 2011-08-17 grant
CA2493479C (en) 2011-10-04 grant
US20080045783A1 (en) 2008-02-21 application
US9278158B2 (en) 2016-03-08 grant
WO2004010908A1 (en) 2004-02-05 application

Similar Documents

Publication Publication Date Title
US4982731A (en) Implantable system and method for augmenting penile erection
US6946002B2 (en) Intragastric stent for duodenum bypass
US5389091A (en) Site-selective durability-enhanced catheter and methods of manufacturing and using same
US7207936B2 (en) Careful impotence treatment apparatus
US4686973A (en) Method of making an intramedullary bone plug and bone plug made thereby
US6309367B1 (en) Aneurysm shield
US6632235B2 (en) Inflatable device and method for reducing fractures in bone and in treating the spine
US6183520B1 (en) Method of maintaining urinary continence
US20050283041A1 (en) Device for generating an artificial constriction in the gastrointestinal tract
US7044981B2 (en) Ureteral stent configured for improved patient comfort and aftercare
US6364868B1 (en) Ureteral catheter and tissue expander and method of megaureter creation
US3863622A (en) Incontinence system and methods of implanting and using same
US20070299043A1 (en) Anti-scarring drug combinations and use thereof
US4610690A (en) Rupture resistant prosthesis with bonded surface layer and method of forming same
US4902293A (en) Intraocular lens with inflatable haptic
US7108655B2 (en) Endourethral device and method
US4624657A (en) Medical devices having inflatable portions
US20070049790A1 (en) Adjustable surgical sling
US7311717B2 (en) Device for generating an artificial constriction in the gastrointestinal tract
US5067485A (en) Corpus cavernosum implant device
US20090254179A1 (en) Method and apparatus for minimally invasive implants
US5059123A (en) Periodontal barrier and method for aiding periodontal tissue regeneration
US5358518A (en) Artificial venous valve
US4515593A (en) Medical tubing having exterior hydrophilic coating for microbiocide absorption therein and method for using same
US4790810A (en) Ureteral connector stent

Legal Events

Date Code Title Description
AS Assignment

Owner name: PROSTHESICA AG,SWITZERLAND

Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:FORSELL, PETER;REEL/FRAME:024051/0300

Effective date: 20091117

AS Assignment

Owner name: PROSTHESICA AG,SWITZERLAND

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE ADDITIONAL PAGES (ATTACHMENT A) TO BE ADDED TO THE ASSIGNMENT.PREVIOUSLY RECORDED ON REEL 024051 FRAME 0300. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNOR:FORSELL, PETER;REEL/FRAME:024064/0562

Effective date: 20091117

AS Assignment

Owner name: ABDOMICA AG,SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AG, PROSTHESICA;REEL/FRAME:024098/0638

Effective date: 20100315